Mark R. Bruder

707 total citations
17 papers, 549 citations indexed

About

Mark R. Bruder is a scholar working on Molecular Biology, Biomedical Engineering and Genetics. According to data from OpenAlex, Mark R. Bruder has authored 17 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Biomedical Engineering and 3 papers in Genetics. Recurrent topics in Mark R. Bruder's work include Insect Resistance and Genetics (5 papers), Biofuel production and bioconversion (5 papers) and CRISPR and Genetic Engineering (5 papers). Mark R. Bruder is often cited by papers focused on Insect Resistance and Genetics (5 papers), Biofuel production and bioconversion (5 papers) and CRISPR and Genetic Engineering (5 papers). Mark R. Bruder collaborates with scholars based in Canada, Brazil and United States. Mark R. Bruder's co-authors include C. Perry Chou, Murray Moo‐Young, Duane A. Chung, Michael E. Pyne, Marie T. Nolan, Marc G. Aucoin, Kajan Srirangan, Adam Westbrook, Lamees Akawi and Stanislav Sokolenko and has published in prestigious journals such as Applied and Environmental Microbiology, Scientific Reports and Applied Microbiology and Biotechnology.

In The Last Decade

Mark R. Bruder

17 papers receiving 538 citations

Peers

Mark R. Bruder

GENET

PHEOH

Mingzhu Yuan China

Stephen Rogers United States

Mads Frederik Hansen Denmark

Michael Y. Kiriukhin Russia

Tatyana A. Sysoeva United States

Hafid Abaibou France

Gabriele Beckers Germany

Monika Singh India

Andrew Haydock United States

Ida Bonde Denmark

Mingzhu Yuan China

Mark R. Bruder

387 ×0.9

73 ×0.4

36 ×0.4

GENET

39 ×0.5

PHEOH

33 ×0.6

Citations per year, relative to Mark R. Bruder Mark R. Bruder (= 1×) peers Mingzhu Yuan

Countries citing papers authored by Mark R. Bruder

Since Specialization

Citations

This map shows the geographic impact of Mark R. Bruder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Bruder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Bruder more than expected).

Fields of papers citing papers by Mark R. Bruder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Bruder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Bruder. The network helps show where Mark R. Bruder may publish in the future.

Co-authorship network of co-authors of Mark R. Bruder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Bruder. A scholar is included among the top collaborators of Mark R. Bruder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Bruder. Mark R. Bruder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Bruder, Mark R., et al.. (2024). Probing Baculovirus Vector Gene Essentiality for Foreign Gene Expression Using a CRISPR-Cas9 System. Methods in molecular biology. 2829. 127–156. 1 indexed citations

Rodríguez‐Ramos, Tania, Fábio S. Zanuzzo, Mark R. Bruder, et al.. (2023). Expression of Interleukin-1β protein in vitro, ex vivo and in vivo salmonid models. Developmental & Comparative Immunology. 147. 104767–104767. 14 indexed citations

Bruder, Mark R. & Marc G. Aucoin. (2023). A sensitive assay for scrutiny of Autographa californica multiple nucleopolyhedrovirus genes using CRISPR-Cas9. Applied Microbiology and Biotechnology. 107(13). 4323–4335. 2 indexed citations

Bruder, Mark R. & Marc G. Aucoin. (2023). Evaluation of Virus-Free Manufacture of Recombinant Proteins Using CRISPR-Mediated Gene Disruption in Baculovirus-Infected Insect Cells. Vaccines. 11(2). 225–225. 9 indexed citations

Bruder, Mark R. & Marc G. Aucoin. (2022). Utility of Alternative Promoters for Foreign Gene Expression Using the Baculovirus Expression Vector System. Viruses. 14(12). 2670–2670. 9 indexed citations

Bruder, Mark R., et al.. (2021). Strain engineering and bioprocessing strategies for biobased production of porphobilinogen in Escherichia coli. Bioresources and Bioprocessing. 8(1). 122–122. 3 indexed citations

Bruder, Mark R., et al.. (2021). Virus matrix interference on assessment of virucidal activity of high-touch surfaces designed to prevent hospital-acquired infections. Antimicrobial Resistance and Infection Control. 10(1). 133–133. 11 indexed citations

Bruder, Mark R., et al.. (2021). Comparison of CRISPR–Cas9 Tools for Transcriptional Repression and Gene Disruption in the BEVS. Viruses. 13(10). 1925–1925. 11 indexed citations

Westbrook, Adam, et al.. (2018). Strain engineering for microbial production of value-added chemicals and fuels from glycerol. Biotechnology Advances. 37(4). 538–568. 38 indexed citations

10.

Pyne, Michael E., Mark R. Bruder, Murray Moo‐Young, Duane A. Chung, & C. Perry Chou. (2016). Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium. Scientific Reports. 6(1). 25666–25666. 140 indexed citations

11.

Pyne, Michael E., Stanislav Sokolenko, Kajan Srirangan, et al.. (2016). Disruption of the Reductive 1,3-Propanediol Pathway Triggers Production of 1,2-Propanediol for Sustained Glycerol Fermentation by Clostridium pasteurianum. Applied and Environmental Microbiology. 82(17). 5375–5388. 26 indexed citations

12.

Srirangan, Kajan, et al.. (2016). Engineering Escherichia coli for Microbial Production of Butanone. Applied and Environmental Microbiology. 82(9). 2574–2584. 22 indexed citations

13.

Srirangan, Kajan, et al.. (2016). Recent advances in engineering propionyl-CoA metabolism for microbial production of value-added chemicals and biofuels. Critical Reviews in Biotechnology. 37(6). 701–722. 14 indexed citations

14.

Bruder, Mark R., Michael E. Pyne, Murray Moo‐Young, Duane A. Chung, & C. Perry Chou. (2016). Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium. Applied and Environmental Microbiology. 82(20). 6109–6119. 56 indexed citations

15.

Bruder, Mark R., Murray Moo‐Young, Duane A. Chung, & C. Perry Chou. (2015). Elimination of carbon catabolite repression in Clostridium acetobutylicum—a journey toward simultaneous use of xylose and glucose. Applied Microbiology and Biotechnology. 99(18). 7579–7588. 48 indexed citations

16.

Pyne, Michael E., Mark R. Bruder, Murray Moo‐Young, Duane A. Chung, & C. Perry Chou. (2014). Technical guide for genetic advancement of underdeveloped and intractable Clostridium. Biotechnology Advances. 32(3). 623–641. 67 indexed citations

17.

Nolan, Marie T. & Mark R. Bruder. (1997). Patients' attitudes toward advance directives and end-of-life treatment decisions. Nursing Outlook. 45(5). 204–208. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact